Bisphosphonates in the Treatment of Osteoporosis-Reference-Cited by-同舟云学术

Bisphosphonates in the Treatment of Osteoporosis

Published:2012-09 Issue:3 Volume:41 Page:487-506
ISSN:0889-8529
Container-title:Endocrinology and Metabolism Clinics of North America
language:en
Short-container-title:Endocrinology and Metabolism Clinics of North America

Author:

Diab Dima L.,Watts Nelson B.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference123 articles.

1. Bisphosphonate treatment for osteoporosis;Watts,2000

2. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy;Russell;Osteoporos Int,2008

3. Molecular mechanisms of action of bisphosphonates;Rogers;Bone,1999

4. Ten years' experience with alendronate for osteoporosis in postmenopausal women;Bone;N Engl J Med,2004

5. Effects of continuing or stopping alendronate after 5 years of treatment. The Fracture Intervention Trial long-term extension (FLEX): a randomized trial;Black;JAMA,2006

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonates do not affect healing of a critical-size defect in estrogen-deficient mice;Bone Reports;2024-03

2. Strategies to reduce the onset of sleeve gastrectomy associated bone loss (STRONG BONES): Trial design and methods;Contemporary Clinical Trials Communications;2023-08

3. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune–Albright Syndrome;International Journal of Molecular Sciences;2023-01-29

4. Asiatic acid improves high-fat-diet-induced osteoporosis in mice via regulating SIRT1/FOXO1 signaling and inhibiting oxidative stress;HISTOL HISTOPATHOL;2022

5. Biologics in Osteoporosis;Handbook of Biologics for Rheumatological Disorders;2022